Tenet Health Edutech Selects Evidex Signal Detection and Management Platform
Summary
With this agreement, Tenet’s subsidiary Cliniminds (http://www.cliniminds.com) will accelerate signal detection and management training of the next generation of pharmacovigilance professionals globally. Additionally, Tenet’s subsidiary Think-I (http://www.thinki.in) will offer Evidex’s signal detection and management platform to their valued pharmaceutical clients. “The management team and the network of companies that make up Tenet Health Edutech are ideally suited to help us achieve two primary goals – to expand our marketing reach in India and other key global markets and to increase the use of Evidex as a training tool for the next generation of pharmacovigilance leaders.” “After surveying the market for signal detection and management software, it is clear to us that Advera Health’s Evidex represents the next generation of pharmacovigilance software,” said Kamal Shahani, Managing Director of Tenet Health Edutech. “With this agreement, we can now offer our pharmaceutical clients and pharmacovigilance trainees an end-to-end drug safety solution that positions them for the challenges and opportunities that lie ahead in the coming decades.” Since launching Evidex, Advera Health has been creating a next generation pharmacovigilance platform to connect disparate drug safety data sources and provide a user experience that elicits actionable intelligence from those data. Think-i, the consulting arm of the business, offers wide range of services to the pharma industry including various global software solutions in the Signal Management, eQMS and Safety Database.
Classifications
AskAI Classifications
LabelsLinked Companies
